No image available
No image available
Your request is being processed.
Home
Products
Applications & Technologies
Contact Us


Cell Therapy Processing

Cell Therapy Processing

VISIT THE BIOSAFE WEBSITE

GE acquires Biosafe SA

Combining portfolios to enable the development of cell therapies

 


 

Cell Therapy Manufacturing Social Platforms. Stay connected.

* Meet USP <1043> ‘ancillary materials for cell, gene, and tissue-engineered products’, within the responsibilities applicable to a supplier. Other aspects of USP <1043> will be the responsibility of the end-user to assess. GE Healthcare cannot fulfill USP <1043> in regards to application and therapy specific aspects